Elos Medtech Statements
EL
Data from Elos Medtech`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
SEK - Swedish krone
Last reporting period:
30 Sep, 2023
Next reporting period:
29 Dec, 2023
Report frequency:
Quarterly
Earnings release date:
—
Expected release date:
—
Elos Medtech Income Statement
B
M
SEK (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
251.2
-6.9 %
100
161.6
64.3
89.6
-1.5 %
35.7
4
1.6
54.1
21.5
57.9
-4.9 %
23
31.7
5.3 %
12.6
-0.8
-0.3
—
0
30.9
125.5 %
12.3
9.3
3.7
21.6
129.8 %
8.6
2.68
8.06
269.8
1 %
100
178.8
66.3
91
-3.2 %
33.7
5.5
2
55.8
20.7
60.9
22.8 %
22.6
30.1
-32.2 %
11.2
-16.4
-6.08
—
0
13.7
-55.5 %
5.1
4.3
1.6
9.4
-60 %
3.5
1.165
8.068
267.2
16.5 %
100
173.2
64.8
94
41.3 %
35.2
5.9
2.2
43.9
16.4
49.6
1.6 %
18.6
44.4
150.9 %
16.6
-13.6
-5.09
—
0
30.8
1949.2 %
11.5
7.3
2.7
23.5
5122.2 %
8.8
2.913
8.068
229.44
-0.9 %
100
162.92
71
66.521
-21.3 %
29
5.826
2.5
42.552
18.5
48.825
4.3 %
21.3
17.696
-53.1 %
7.7
-16.193
-7.06
—
0
1.503
-94.8 %
0.7
0.953
0.4
0.45
-97.9 %
0.2
0.056
8.068
231.5
-0.7 %
100
147
63.5
84.5
-1.6 %
36.5
6.1
2.6
41.7
18
46.8
-2.7 %
20.2
37.7
-0.3 %
16.3
-8.7
-3.8
—
0
29
-25.3 %
12.5
7.2
3.1
21.9
-26.3 %
9.5
2.714
8.068
233.1
19.8 %
100
147.2
63.1
85.9
16.7 %
36.9
6.5
2.8
43.1
18.5
48.1
8.3 %
20.6
37.8
29.5 %
16.2
1.1
0.5
-0.1
-0.04
38.8
30.2 %
16.6
9.1
3.9
29.7
29.1 %
12.7
3.681
8.068
194.5
5.6 %
100
120.9
62.2
73.6
17.2 %
37.8
6
3.1
38.4
19.7
44.4
18.4 %
22.8
29.2
15.5 %
15
0.6
0.3
—
0
29.8
20 %
15.3
6.8
3.5
23
17.4 %
11.8
2.851
8.068
184.18
-1.6 %
100
121.39
65.9
62.793
-7.8 %
34.1
5.161
2.8
34.758
18.9
37.502
-14.6 %
20.4
25.291
4.5 %
13.7
-0.467
-0.3
—
0
24.824
6.5 %
13.5
5.234
2.8
19.59
11.3 %
10.6
2.419
8.099
187.2
3.4 %
100
119.1
63.6
68.1
4.1 %
36.4
3.9
2.1
39.7
21.2
43.9
12.9 %
23.5
24.2
-8.7 %
12.9
-0.9
-0.5
—
0
23.3
2.2 %
12.4
5.7
3
17.6
-4.3 %
9.4
2.18
8.073
181
5.7 %
100
115.6
63.9
65.4
10.5 %
36.1
4.2
2.3
35
19.3
38.9
13.7 %
21.5
26.5
6 %
14.6
-3.7
-2.04
—
0
22.8
-15.9 %
12.6
4.4
2.4
18.4
-8 %
10.2
2.28
8.07
171.2
10.6 %
100
112
65.4
59.2
13.4 %
34.6
4.4
2.6
29.4
17.2
34.2
2.7 %
20
25
32.2 %
14.6
2.1
1.2
—
0
27.1
102.8 %
15.8
7.1
4.1
20
79.7 %
11.7
2.479
8.068
154.8
4.7 %
100
102.58
66.3
52.222
9.9 %
33.7
3.372
2.2
28.863
18.6
33.305
12.5 %
21.5
18.917
5.7 %
12.2
-2.227
-1.4
-3.33
-2.2
13.36
-5.9 %
8.6
2.228
1.4
11.132
-11.7 %
7.2
1.38
8.068
147.9
25 %
100
100.4
67.9
47.5
18.8 %
32.1
4.2
2.8
26.1
17.6
29.6
17.9 %
20
17.9
20.1 %
12.1
-3.7
-2.5
—
0
14.2
56 %
9.6
1.6
1.1
12.6
82.6 %
8.5
1.562
8.068
118.3
-25.6 %
100
78.3
66.2
40
-16.8 %
33.8
2.8
2.4
22
18.6
25.1
-30.7 %
21.2
14.9
25.2 %
12.6
-5.8
-4.9
—
0
9.1
37.9 %
7.7
2.2
1.9
6.9
27.8 %
5.8
0.855
8.068
158.9
0.4 %
100
110.8
69.7
48.1
-2.9 %
30.3
5.2
3.3
32
20.1
36.2
2.3 %
22.8
11.9
-15.8 %
7.5
-5.3
-3.3
—
0
6.6
-34.1 %
4.2
1.2
0.8
5.4
-29 %
3.4
0.669
8.068
158.3
0.8 %
100
108.77
68.7
49.528
3.6 %
31.3
4.297
2.7
31.225
19.7
35.401
5.4 %
22.4
14.127
-0.5 %
8.9
-4.137
-2.6
0.02
0.01
10.01
-12.2 %
6.3
2.408
1.5
7.602
-15.5 %
4.8
0.942
8.068
157.1
-14.7 %
100
109.3
69.6
47.8
-14.8 %
30.4
3.2
2
31.1
19.8
33.6
-17 %
21.4
14.2
-9 %
9
-2.8
-1.8
—
0
11.4
32.6 %
7.3
2.4
1.5
9
36.4 %
5.7
1.116
8.068
184.1
—
100
128
69.5
56.1
—
30.5
4.4
2.4
36.7
19.9
40.5
—
22
15.6
—
8.5
-7
-3.8
—
0
8.6
—
4.7
2
1.1
6.6
—
3.6
0.818
8.068